New Operating Cycle from 2010 to 2026
| BBAL Stock | USD 0.0001 0.00 0.00% |
Operating Cycle | First Reported 2010-12-31 | Previous Quarter 79.75 | Current Value 87.7 | Quarterly Volatility 6.31455675 |
Check New York financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among New York's main balance sheet or income statement drivers, such as Interest Expense of 0.0, Selling General Administrative of 10.2 M or Total Revenue of 44.6 M, as well as many indicators such as Price To Sales Ratio of 0.0454, Dividend Yield of 0.0015 or Days Sales Outstanding of 87.7. New financial statements analysis is a perfect complement when working with New York Valuation or Volatility modules.
New | Operating Cycle | Build AI portfolio with New Stock |
Historical Operating Cycle data for New York serves as a key indicator of operational performance and financial stability. Tracking changes in this metric over time helps investors spot emerging trends before they become obvious, providing an edge in assessing whether New York Health represents a compelling investment opportunity.
Latest New York's Operating Cycle Growth Pattern
Below is the plot of the Operating Cycle of New York Health over the last few years. It is New York's Operating Cycle historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in New York's overall financial position and show how it may be relating to other accounts over time.
| Operating Cycle | 10 Years Trend |
|
Operating Cycle |
| Timeline |
New Operating Cycle Regression Statistics
| Arithmetic Mean | 72.10 | |
| Geometric Mean | 71.86 | |
| Coefficient Of Variation | 8.76 | |
| Mean Deviation | 4.52 | |
| Median | 69.35 | |
| Standard Deviation | 6.31 | |
| Sample Variance | 39.87 | |
| Range | 18.3496 | |
| R-Value | 0.15 | |
| Mean Square Error | 41.58 | |
| R-Squared | 0.02 | |
| Significance | 0.57 | |
| Slope | 0.19 | |
| Total Sum of Squares | 637.98 |
New Operating Cycle History
About New York Financial Statements
New York investors utilize fundamental indicators, such as Operating Cycle, to predict how New Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Operating Cycle | 79.75 | 87.70 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ProphetCheck out the analysis of New York Correlation against competitors. You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Is Health Care Providers & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of New York. Projected growth potential of New fundamentally drives upward valuation adjustments. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive New York assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of New York Health is measured differently than its book value, which is the value of New that is recorded on the company's balance sheet. Investors also form their own opinion of New York's value that differs from its market value or its book value, called intrinsic value, which is New York's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because New York's market value can be influenced by many factors that don't directly affect New York's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between New York's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding New York should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, New York's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.